We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQDG icon
6776
WisdomTree International Quality Dividend Growth Fund
IQDG
$734M
$23K ﹤0.01%
711
-2,744
-79% -$83.3K
MNKD icon
6777
MannKind Corp
MNKD
$1.32B
$23K ﹤0.01%
17,973
+14,000
+352% +$17.9K
MREO
6778
Mereo BioPharma
MREO
$47.3M
$23K ﹤0.01%
6,969
+5,845
+520% +$14.9K
PAVM icon
6779
PAVmed
PAVM
$33.9M
$23K ﹤0.01%
+43
New +$17.9K
PRTH icon
6780
Priority Technology Holdings
PRTH
$444M
$23K ﹤0.01%
9,174
+249
+3% +$866
RSP icon
6781
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$23K ﹤0.01%
+200
New +$22.2K
XENE icon
6782
Xenon Pharmaceuticals
XENE
$6.12B
$23K ﹤0.01%
1,753
+522
+42% +$5.49K
PMD
6783
DELISTED
Psychemedics Corporation
PMD
$23K ﹤0.01%
2,533
+623
+33% +$5.75K
ESCR
6784
DELISTED
Xtrackers Bloomberg US Investment Grade Corporate ESG ETF
ESCR
$23K ﹤0.01%
967
-151
-14% -$3.55K
VST.WS.A
6785
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$23K ﹤0.01%
10,828
-1,803
-14% -$3.62K
SIOX
6786
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$23K ﹤0.01%
4,469
-32,048
-88% -$178K
MITO
6787
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$23K ﹤0.01%
7,000
+286
+4% +$2.19K
GPL
6788
DELISTED
Great Panther Mining Limited
GPL
$23K ﹤0.01%
4,494
-1,805
-29% -$9.52K
DMRL
6789
DELISTED
DeltaShares S&P 500 Managed Risk ETF
DMRL
$23K ﹤0.01%
383
-692
-64% -$40.6K
ARD
6790
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$23K ﹤0.01%
1,153
+985
+586% +$18.1K
NPAUU
6791
DELISTED
New Providence Acquisition Corp. Unit
NPAUU
$23K ﹤0.01%
2,205
-5,200
-70% -$52.8K
MNCLU
6792
DELISTED
Monocle Acquisition Corporation Units
MNCLU
$23K ﹤0.01%
2,090
MUDSU
6793
DELISTED
Mudrick Capital Acquisition Corporation Unit
MUDSU
$23K ﹤0.01%
2,145
-100
-4% -$1.08K
FLY
6794
DELISTED
Fly Leasing Limited
FLY
$23K ﹤0.01%
1,160
+215
+23% +$4.29K
SAGG
6795
DELISTED
Direxion Daily Total Bond Market Bear 1X Shares
SAGG
$23K ﹤0.01%
794
+700
+745% +$20.7K
AQMS icon
6796
Aqua Metals
AQMS
$10.2M
$22K ﹤0.01%
145
-146
-50% -$38K
BANX
6797
ArrowMark Financial
BANX
$199M
$22K ﹤0.01%
1,000
-500
-33% -$11.3K
GSSC icon
6798
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.08B
$22K ﹤0.01%
459
-692
-60% -$31.5K
ITT icon
6799
PUT
ITT
ITT
$19.1B
$22K ﹤0.01%
+300
New +$19.9K
JFU
6800
9F Inc
JFU
$29.1M
$22K ﹤0.01%
112
+105
+1,500% +$22.9K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.